Free Trial

Relx (LON:REL) Earns Buy Rating from UBS Group

Relx logo with Industrials background

Key Points

  • UBS Group has reiterated its "buy" rating for Relx (LON:REL), setting a price target of GBX 4,570, which suggests a potential upside of 36.79%.
  • Relx currently holds a consensus rating of "Moderate Buy" among analysts, with the average target price at GBX 4,520.67.
  • As of Friday, Relx's stock price was GBX 3,341, with a market capitalization of £60.86 billion and a reported EPS of GBX 63.50 for the last quarter.
  • Interested in Relx? Here are five stocks we like better.

Relx (LON:REL - Get Free Report)'s stock had its "buy" rating reiterated by investment analysts at UBS Group in a research report issued to clients and investors on Friday,Digital Look reports. They presently have a GBX 4,570 price target on the stock. UBS Group's target price points to a potential upside of 36.79% from the company's current price.

Several other analysts also recently commented on REL. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Relx from GBX 3,909 to GBX 4,072 and gave the company a "hold" rating in a research report on Friday, July 25th. JPMorgan Chase & Co. raised their target price on shares of Relx from GBX 4,890 to GBX 4,920 and gave the stock an "overweight" rating in a research note on Friday, July 25th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Relx presently has a consensus rating of "Moderate Buy" and a consensus target price of GBX 4,520.67.

Read Our Latest Report on REL

Relx Stock Down 0.4%

LON:REL opened at GBX 3,341 on Friday. Relx has a 1-year low of GBX 2,968 and a 1-year high of GBX 4,205. The firm's 50-day moving average price is GBX 3,476.40 and its 200-day moving average price is GBX 3,775.78. The company has a market capitalization of £60.86 billion, a PE ratio of 3,231.14, a P/E/G ratio of 2.69 and a beta of 0.48. The company has a debt-to-equity ratio of 216.69, a current ratio of 0.48 and a quick ratio of 0.45.

Relx (LON:REL - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The company reported GBX 63.50 EPS for the quarter. Relx had a net margin of 20.34% and a return on equity of 56.71%. On average, equities analysts predict that Relx will post 134.0035675 EPS for the current fiscal year.

Relx Company Profile

(Get Free Report)

RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs over 33,000 people, of whom almost half are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Relx Right Now?

Before you consider Relx, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.

While Relx currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.